1. Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia
- Author
-
Aiman El-Saed, Waleed A. Ahmed, Husam A. Bahaudden, Ahmed M. Hassan, Salim Baharoon, Fatehi Elzein, Esam I. Azhar, Ibtihaj Alsharif, Jincun Zhao, Isamel Qushmaq, Ziad A. Memish, Ashraf Dada, Maha Al-Mozaini, Nazik Eltayeb, Mushira Enani, Laila Layqah, Abdul Haseeb, Yanqun Wang, Stanley Perlman, Sherif A. El-Kafrawy, Abeer N. Alshukairi, Najlaa A. Siddiq, and Sara Alfaraj
- Subjects
Epidemiology ,viruses ,Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia ,Infectious and parasitic diseases ,RC109-216 ,medicine.disease_cause ,patients ,MERS-CoV ,0302 clinical medicine ,Medicine ,030212 general & internal medicine ,antibody responses ,media_common ,biology ,Middle East respiratory syndrome ,Longevity ,Dispatch ,virus diseases ,Infectious Diseases ,Middle East Respiratory Syndrome Coronavirus ,disease severity ,Antibody ,Coronavirus Infections ,Microbiology (medical) ,Camelus ,Middle East respiratory syndrome coronavirus ,media_common.quotation_subject ,coronaviruses ,030231 tropical medicine ,Saudi Arabia ,03 medical and health sciences ,Immune system ,longevity ,MERS ,Animals ,Humans ,Variable disease severity ,business.industry ,biochemical phenomena, metabolism, and nutrition ,medicine.disease ,respiratory tract diseases ,zoonoses ,Antibody response ,Immunology ,Antibody Formation ,biology.protein ,Disease prevention ,business - Abstract
Understanding the immune response to Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for disease prevention and vaccine development. We studied the antibody responses in 48 human MERS-CoV infection survivors who had variable disease severity in Saudi Arabia. MERS-CoV-specific neutralizing antibodies were detected for 6 years postinfection.
- Published
- 2021